Impax Asset Management Group plc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Impax Asset Management Group plc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,088,908
+92.3%
368,640
+131.4%
0.05%
+6.5%
Q2 2023$11,486,972
-19.6%
159,320
-18.0%
0.05%
-23.3%
Q1 2023$14,294,179
-8.7%
194,320
-17.1%
0.06%
-14.3%
Q4 2022$15,652,576
-22.4%
234,3200.0%0.07%
-32.7%
Q3 2022$20,177,000
+22.7%
234,320
+27.1%
0.10%
+30.0%
Q2 2022$16,445,000
-11.0%
184,320
+12.2%
0.08%
+5.3%
Q1 2022$18,484,000
-11.2%
164,320
+21.9%
0.08%0.0%
Q4 2021$20,824,000
+50.5%
134,820
+35.7%
0.08%
+33.3%
Q3 2021$13,837,000
+33.0%
99,320
+25.2%
0.06%
+23.9%
Q2 2021$10,406,000
-19.1%
79,320
-6.0%
0.05%
-30.3%
Q1 2021$12,868,000
+3.0%
84,411
-32.8%
0.07%
-16.5%
Q4 2020$12,488,000
+4.3%
125,5670.0%0.08%
-24.8%
Q3 2020$11,969,000
-8.4%
125,567
+7.5%
0.10%
-21.6%
Q2 2020$13,067,000
+53.8%
116,8290.0%0.13%
+18.6%
Q1 2020$8,496,000
+6.0%
116,829
+52.1%
0.11%
+27.0%
Q4 2019$8,012,000
+11.3%
76,829
+6.3%
0.09%
-5.3%
Q3 2019$7,197,000
-12.8%
72,3030.0%0.09%
-12.1%
Q2 2019$8,253,000
-18.9%
72,303
-10.7%
0.11%
-23.6%
Q1 2019$10,177,000
-7.4%
80,9590.0%0.14%
-21.8%
Q4 2018$10,986,000
+29.3%
80,959
+161.5%
0.18%
+46.7%
Q3 2018$8,498,00030,9590.12%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders